Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SCENT Trial: Nasal Theophylline Irrigation for Treatment of Post-Viral Olfactory Dysfunction

NCT03990766 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT03990766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03990766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SCENT Trial: Nasal Theophylline Irrigation for Treatment of Post-Viral Olfactory Dysfunction
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Completed
Start date
May 15, 2019
Completion date
January 15, 2021
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anosmia, olfactory disorder, smell disorder, theophylline causing adverse effects in therapeutic use, viral infection